FirstpilltotreatCovidgetsapprovalinUK英批准首款抗新冠口服药
AnexperimentalCOVID-19treatmentpillcalledmolnupiravirbeingdevelopedbyMerckCoIncandRidgebackBiotherapeuticsLP,isseeninthisundatedhandoutphotoreleasedbyMerckCoInc,May17,.[Photo/Agencies]
ThefirstpilldesignedtotreatsymptomaticCovid-19hasbeenapprovedbytheUKmedicinesregulator.英国药品监管机构批准了首款用于治疗症状性新冠肺炎的药物。
Thetablet-molnupiravir-willbegiventwiceadaytovulnerablepatientsrecentlydiagnosedwiththedisease.近期确诊新冠肺炎的虚弱患者将每天服用两次莫那比拉韦。
Inclinicaltrials,thepill,originallydevelopedtotreatflu,cuttheriskofhospitalizationordeathbyabouthalf.在临床试验中，该药物将因感染新冠病毒住院或死亡的风险降低了一半左右。该药物原本用于治疗流感。
HealthSecretarySajidJavidsaidthetreatmentwasagamechangerforthemostfrailandimmuno-suppressed.英国卫生大臣赛义德贾维德称，这种药物对身体虚弱和免疫功能不全的人来说意义重大。
Molnupiravir,developedbytheUSdrug